A study to evaluate the effect of belimumab on peripheral blood cells in patients with systemic lupus erythematosus.
Phase of Trial: Phase IV
Latest Information Update: 02 Feb 2016
At a glance
- Drugs Belimumab (Primary)
- Indications Systemic lupus erythematosus
- Focus Pharmacodynamics
- 02 Feb 2016 New trial record